Apolipoprotein e genotype and Alzheimer's disease
Payami, H.; Kaye, J.; Heston, L.L.; Bird, T.D.; Schellenberg, G.D.
Lancet 342(8873): 738
1993
ISSN/ISBN: 0140-6736 PMID: 8103833 Document Number: 418204
Document emailed within 1 workday
Related Documents
Tamaoka, A. 1994: Apolipoprotein E4 and late-onset Alzheimer's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 52(12): 3257-3265Simó, J.M.; Camps, J.; Vilella, E.; Gómez, F.; Paul, A.; Joven, J. 2001: Instability of lipoprotein(a) in plasma stored at -70 degrees C: effects of concentration, apolipoprotein(a) genotype, and donor cardiovascular disease Clinical Chemistry 47(9): 1673-1678
Kowalska, A.; Florczak, J.; Pruchnik-Wolińska, D.; Kraszewski, A.; Wender, M. 1998: Apolipoprotein e genotypes in sporadic early and late-onset Alzheimer's disease Archivum Immunologiae et Therapiae Experimentalis 46(3): 177-181
Wang, J.-t.; Li, L.; Yuan, J.; Zhang, Z.-x. 2013: Correlation between Apolipoprotein e polymorphism and age at onset of Alzheimer's disease in a Chinese Han population Zhonghua Yi Xue Za Zhi 93(3): 182-186
Cui, T.; Zhou, X.; Jin, W.; Zheng, F.; Cao, X. 2000: Gene polymorphism in apolipoprotein e and presenilin-1 in patients with late-onset Alzheimer's disease Chinese Medical Journal 113(4): 340-344
Lai, S.; Chen, Y.; Wen, Z. 2001: Association between apolipoprotein E polymorphism and Alzheimer's disease: A population-based study in Guangzhou, China Zhonghua Liu Xing Bing Xue Za Zhi 22(3): 202-204
Mauri, M.; Sinforiani, E.; Bono, G.; Cittadella, R.; Quattrone, A.; Boller, F.ço.; Nappi, G. 2006: Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment Functional Neurology 21(4): 223-228
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Formiga, F.; Alia, P.; Navarro, M.Angel.; Pujol, Rón. 2005: Apolipoprotein in nonagenarian patients: association between alleles and genotype with prevalent diseases Medicina Clinica 124(9): 356
Ivanchenkova, R.A.; Gatsenko, V.P.; At'kova, E.R.; Meshkov, A.N. 2010: Disorders of lipid metabolism in patients with cholelithiasis and gallbladder cholesterosis depending on apolipoprotein e genotype Klinicheskaia Meditsina 88(4): 43-48
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Joska, J.A.; Combrinck, M.; Valcour, V.G.; Hoare, J.; Leisegang, F.; Mahne, A.Cecilia.; Myer, L.; Stein, D.J. 2010: Association between apolipoprotein E4 genotype and human immunodeficiency virus-associated dementia in younger adults starting antiretroviral therapy in South Africa Journal of Neurovirology 16(5): 377-383
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474
Weber, M.; McNicoll, S.; Marcil, M.; Connelly, P.; Lussier-Cacan, S.; Davignon, J.; Latour, Y.; Genest, J. 1997: Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians Canadian Journal of Cardiology 13(3): 253-260
Szpak, G.M.; Lechowicz, W.; Lewandowska, E.; Bertrand, E.; Wierzba-Bobrowicz, T.; Gwiazda, E.; Schmidt-Sidor, B.; Dymecki, J. 2001: Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study Folia Neuropathologica 39(3): 181-192
Bufill, E.; Blesa, R. 2006: Alzheimer's disease and brain evolution: is Alzheimer's disease an example of antagonistic pleiotropy? Revista de Neurologia 42(1): 25-33
Fărcăşel, L. 1988: Current data on the anatomy and physiopathology of Alzheimer's disease (Alzheimer-type senile dementia--ATSD) Revista Medico-Chirurgicala A Societatii de Medici Si Naturalisti Din Iasi 92(2): 289-292